| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-06-03 | Mr. Mizanu KebedeChief Quality & Regulatory Affairs Officer | 22.19 | 0.00 | 買い | - | 442.00 | 5.29% |
| 2026-06-03 | Mr. Paul ConnollyPresident of Global Operations | 52.01 | 0.00 | 買い | - | 499.00 | 11.64% |
| 2026-06-03 | Dr. Deepak S. NathCEO & Director | 52.17 | 0.00 | 買い | - | 5.11k | 1.03% |
| 2026-06-03 | Mr. Scott SchaffnerPresident of Sports Medicine | 57.57 | 0.00 | 買い | - | 1.70k | 3.51% |
| 2026-05-05 | Cevian Capital AB法人 | 9.58M | 143.66M | 買い | 14.61 - 15.58 | 101.05M | 10.48% |
| 2026-05-27 | Mr. John Terence RogersCFO & Executive Director | 61.90 | 945.87 | Acquisition Under Employee Benefit Plan | 15.28 | 77.22k | 0.08% |
| 2026-05-27 | Mr. Scott SchaffnerPresident of Sports Medicine | 2.15k | 32.83k | Acquisition Under Employee Benefit Plan | 15.28 | 73.41k | 3.01% |
| 2026-05-27 | Dr. Deepak S. NathCEO & Director | 6.26k | 95.65k | Acquisition Under Employee Benefit Plan | 15.28 | 414.72k | 1.53% |
| 2026-05-27 | Mr. Paul ConnollyPresident of Global Operations | 1.19k | 18.18k | Acquisition Under Employee Benefit Plan | 15.28 | 38.00k | 3.23% |
| 2026-05-27 | Ms. Alison ParkesCCO & Compliance APAC | 153.59 | 2.35k | Acquisition Under Employee Benefit Plan | 15.28 | 1.41k | 12.22% |
| 2026-03-17 | Cevian Capital AB法人 | 9.77M | 158.64M | 買い | 15.44 - 17.06 | 91.46M | 11.97% |
| 2026-04-15 | Dr. Deepak S. NathCEO & Director | 50.00 | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-15 | Mr. Craig GaffinPresident of Global Orthopaedics | 50.00 | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-15 | Mr. Mizanu KebedeChief Quality & Regulatory Affairs Officer | 50.00 | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-15 | Mr. Paul ConnollyPresident of Global Operations | 50.00 | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-15 | Mr. John Terence RogersCFO & Executive Director | 50.00 | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-15 | Mr. Scott SchaffnerPresident of Sports Medicine | 50.00 | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-15 | Dr. Rohit KashyapPresident of Advanced Wound Management & Global Commercial Operations | 50.00 | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-15 | Dr. Vasant PadmanabhanPresident Research & Development, ENT and Emerging Markets | 50.00 | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-15 | Ms. Elga LohlerChief HR Officer | 50.00 | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-15 | Ms. Helen BarracloughGroup General Counsel & Company Secretary | 50.00 | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-15 | Ms. Alison ParkesCCO & Compliance APAC | 50.00 | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-15 | Dr. Ajay DhankharChief Corporate Development & Strategy Officer | 50.00 | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-01 | Mr. John Terence RogersCFO & Executive Director | 266.56k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-01 | Dr. Ajay DhankharChief Corporate Development & Strategy Officer | 152.76k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-01 | Mr. Craig GaffinPresident of Global Orthopaedics | 115.49k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-01 | Ms. Elga LohlerChief HR Officer | 102.51k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-01 | Mr. Paul ConnollyPresident of Global Operations | 77.97k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-01 | Dr. Rohit KashyapPresident of Advanced Wound Management & Global Commercial Operations | 167.34k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-01 | Dr. Vasant PadmanabhanPresident Research & Development, ENT and Emerging Markets | 99.09k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-01 | Mr. Mizanu KebedeChief Quality & Regulatory Affairs Officer | 75.21k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-01 | Ms. Alison ParkesCCO & Compliance APAC | 27.06k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-01 | Mr. Scott SchaffnerPresident of Sports Medicine | 172.02k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-01 | Dr. Deepak S. NathCEO & Director | 487.91k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-01 | Ms. Helen BarracloughGroup General Counsel & Company Secretary | 77.48k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-01-20 | Cevian Capital AB法人 | 4.92M | 80.44M | 買い | 15.84 - 16.53 | 81.69M | 6.41% |
| 2026-01-16 | Mr. Scott SchaffnerPresident of Sports Medicine | 242.59 | 6.28k | Acquisition Under Employee Benefit Plan | 25.90 | 1.67k | 17.02% |
| 2026-01-16 | Dr. Deepak S. NathCEO & Director | 410.11 | 10.62k | Acquisition Under Employee Benefit Plan | 25.90 | 5.08k | 8.77% |
| 2026-01-16 | Mr. Craig GaffinPresident of Global Orthopaedics | 206.80 | 5.36k | Acquisition Under Employee Benefit Plan | 25.90 | 305.00 | 210.58% |
| 2026-01-16 | Mr. Paul ConnollyPresident of Global Operations | 410.11 | 10.62k | Acquisition Under Employee Benefit Plan | 25.90 | 473.00 | 652.05% |
| 2025-11-11 | Mr. Scott SchaffnerPresident of Sports Medicine | 29.15 | 970.62 | Acquisition Under Employee Benefit Plan | 33.29 | 1.55k | 1.92% |
| 2025-11-11 | Dr. Deepak S. NathCEO & Director | 24.81 | 825.95 | Acquisition Under Employee Benefit Plan | 33.29 | 4.88k | 0.51% |
| 2025-11-11 | Mr. Craig GaffinPresident of Global Orthopaedics | 22.51 | 749.40 | Acquisition Under Employee Benefit Plan | 33.29 | 202.00 | 12.54% |
| 2025-11-11 | Mr. Mizanu KebedeChief Quality & Regulatory Affairs Officer | 12.03 | 400.62 | Acquisition Under Employee Benefit Plan | 33.29 | 431.00 | 2.87% |
| 2025-11-11 | Mr. Paul ConnollyPresident of Global Operations | 24.72 | 822.98 | Acquisition Under Employee Benefit Plan | 33.29 | 268.00 | 10.16% |
| 2025-11-11 | Dr. Deepak S. NathCEO & Director | 1.78k | 0.00 | Derivative Exercise and Retained Stock | - | 296.13k | 0.60% |
| 2025-11-11 | Dr. Deepak S. NathCEO & Director | -1.24k | 20.53k | Derivative Exercise and Sale | 16.56 | 296.13k | - |
| 2025-11-07 | Mr. Scott SchaffnerPresident of Sports Medicine | 746.79 | 12.20k | Acquisition Under Employee Benefit Plan | 16.33 | 71.26k | 1.06% |
| 2025-11-07 | Dr. Deepak S. NathCEO & Director | 2.62k | 42.86k | Acquisition Under Employee Benefit Plan | 16.33 | 294.35k | 0.90% |
| 2025-11-07 | Mr. Mizanu KebedeChief Quality & Regulatory Affairs Officer | 4.17 | 68.15 | Acquisition Under Employee Benefit Plan | 16.33 | 10.81k | 0.04% |
| 2025-11-07 | Mr. Paul ConnollyPresident of Global Operations | 394.42 | 6.44k | Acquisition Under Employee Benefit Plan | 16.33 | 36.81k | 1.08% |
| 2025-09-09 | Dr. Vasant PadmanabhanPresident Research & Development, ENT and Emerging Markets | -17.64k | 340.22k | 売り | 19.28 | 135.56k | -11.52% |
| 2025-08-27 | Dr. Ajay DhankharChief Corporate Development & Strategy Officer | 249.31k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-08-22 | Mr. Simon Jonathan LowthIndependent Non-Executive Director | 355.00 | 6.65k | 買い | 18.73 | 655.00 | 118.33% |
| 2025-08-22 | Ms. Angela Susan Risleyインサイダー | 373.00 | 6.98k | 買い | 18.71 | 6.35k | 6.24% |
| 2025-08-22 | Mr. Jeremy Kim MaidenIndependent Non-Executive Director | 353.00 | 6.59k | 買い | 18.66 | 3.50k | 11.21% |
| 2025-08-22 | Dr. Katarzyna Mazur-HofsaessIndependent Non-Executive Director | 541.00 | 10.14k | 買い | 18.74 | 2.37k | 29.56% |
| 2025-08-22 | Ms. Joanna Christine HallasIndependent Non-Executive Director | 389.00 | 7.29k | 買い | 18.73 | 6.58k | 6.28% |
| 2025-08-22 | Mr. Marc Ellis OwenIndependent Non-Executive Director | 202.00 | 7.52k | 買い | 37.25 | 0.00 | -100.00% |
| 2025-08-22 | Dr. Changzheng MaIndependent Non-Executive Director | 305.00 | 11.36k | 買い | 37.25 | 0.00 | -100.00% |
| 2025-08-20 | Ms. Sybella Jane StanleyIndependent Non-Executive Director | 1.52k | 28.48k | 買い | 18.73 | 5.33k | 39.90% |
| 2025-08-18 | Dr. Deepak S. NathCEO & Director | 25.83k | 0.00 | Derivative Exercise and Retained Stock | - | 291.73k | 9.72% |
| 2025-08-18 | Dr. Deepak S. NathCEO & Director | -18.01k | 328.90k | Derivative Exercise and Sale | 18.27 | 291.73k | - |
| 2025-08-06 | Ms. Elga LohlerChief HR Officer | -12.56k | 224.69k | 売り | 17.89 | 177.82k | -6.60% |
| 2025-07-09 | Mr. Scott SchaffnerPresident of Sports Medicine | 298.19 | 8.88k | Acquisition Under Employee Benefit Plan | 29.77 | 1.53k | 24.21% |
| 2025-07-09 | Dr. Deepak S. NathCEO & Director | 512.30 | 15.25k | Acquisition Under Employee Benefit Plan | 29.77 | 4.87k | 11.76% |
| 2025-07-09 | Mr. Craig GaffinPresident of Global Orthopaedics | 381.29 | 11.35k | Acquisition Under Employee Benefit Plan | 29.77 | 191.00 | -200.37% |
| 2025-07-09 | Mr. Mizanu KebedeChief Quality & Regulatory Affairs Officer | 114.62 | 3.41k | Acquisition Under Employee Benefit Plan | 29.77 | 425.00 | 36.93% |
| 2025-07-09 | Mr. Paul ConnollyPresident of Global Operations | 512.30 | 15.25k | Acquisition Under Employee Benefit Plan | 29.77 | 256.00 | -199.88% |
| 2025-05-14 | Cevian Capital AB法人 | 7.99M | 115.98M | 買い | 14.07 - 15.17 | 74.47M | 12.02% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。